Evidence map›Paper›PMID 30531720›Full record

ArticleJournal of visualized experiments : JoVE2018

Unraveling Key Players of Humoral Immunity: Advanced and Optimized Lymphocyte Isolation Protocol from Murine Peyer's Patches.

Yavuz F Yazicioglu, Halil I Aksoylar, Rinku Pal, Nikolaos Patsoukis, Vassiliki A Boussiotis

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yavuz F YaziciogluDivision of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School.
Halil I AksoylarDivision of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School.
Rinku PalDivision of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School.
Nikolaos PatsoukisDivision of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School.
Vassiliki A BoussiotisDivision of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School; vboussio@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · US

Funding

Effects of PGE2 on Reconstitution of Hematopoiesis and Immunity after UCBTR01CA183605 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BOUSSIOTIS, VASSILIKI A, CUTLER, COREY S · 2013 to 2017
$3.8M
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effectR01CA212605 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BOUSSIOTIS, VASSILIKI A · 2017 to 2021
$2.8M
NCI NIH HHS R01 CA183605NCI NIH HHS R01 CA212605
6 · The paper itself

Abstract

In the gut mucosa, immune cells constitute a unique immunological entity, which promotes immune tolerance while concurrently conferring immune defense against pathogens. It is well established that Peyer's patches (PPs) have an essential role in the mucosal immune network by hosting several effector T and B cell subsets. A certain fraction of these effector cells, follicular T helper (TFH) and germinal center (GC) B cells are professionalized in the regulation of humoral immunity. Hence, the characterization of these cell subsets within PPs in terms of their differentiation program and functional properties can provide important information about mucosal immunity. To this end, an easily applicable, efficient and reproducible method of lymphocyte isolation from PPs would be valuable to researchers. In this study, we aimed to generate an effective method to isolate lymphocytes from mouse PPs with high cell yield. Our approach revealed that initial tissue processing such as the use of digestive reagents and tissue agitation, as well as cell staining conditions and selection of antibody panels, have great influence on the quality and identity of the isolated lymphocytes and on experimental outcomes. Here, we describe a protocol enabling researchers to efficiently isolate lymphocyte populations from PPs allowing reproducible flow cytometry-based assessment of T and B cell subsets primarily focusing on TFH and GC B cell subsets.

Indexed as

AnimalsB-LymphocytesCell DifferentiationFlow CytometryGerminal CenterImmunity, HumoralImmunity, MucosalMicePeyer's PatchesT-Lymphocytes, Helper-Inducer

Identifiers

PMID30531720
PMCPMC10947548
OpenAlexW2900503326

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.